Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167004 | SCV000217827 | pathogenic | Hereditary cancer-predisposing syndrome | 2014-12-08 | criteria provided, single submitter | clinical testing | The c.3821dupT pathogenic mutation, located in coding exon 28 of the NF1 gene, results from a duplication of T at nucleotide position 3821, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |
Labcorp Genetics |
RCV001050019 | SCV001214105 | pathogenic | Neurofibromatosis, type 1 | 2019-05-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant has not been reported in the literature in individuals with NF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 187286). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe1275Leufs*9) in the NF1 gene. It is expected to result in an absent or disrupted protein product. |
Genome- |
RCV001050019 | SCV002559992 | pathogenic | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |